Lv1
96 积分 2026-02-04 加入
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
6个月前
已完结
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
6个月前
已完结
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
6个月前
已完结
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
6个月前
已完结
Diagnosis and Management of Nonalcoholic Fatty Liver Disease
6个月前
已完结
Genetics and epigenetics of NAFLD and NASH: Clinical impact
6个月前
已完结
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
6个月前
已完结
Role of gut-liver axis dysfunction in pathogenesis of non-alcoholic fatty liver disease: Implications for treatment strategies
7个月前
已完结
Metabolomics as a promising technology for investigating external therapy of traditional Chinese medicine: A review
7个月前
已完结
Mechanisms of NAFLD development and therapeutic strategies
7个月前
已完结
皖公网安备34019202002308
